Urgent one-stage endoscopic treatment for choledocholithiasis related moderate to severe acute cholangitis: A propensity score-matched analysis

Table 2 Outcomes of endoscopic retrograde cholangiopancreatography

	Before matching				After matching
	Total, n = 254	ERCP ≤ 24 h, n = 102	ERCP > 24 h, n = 152	P value	Total, n = 186	ERCP ≤ 24 h, n = 93	ERCP > 24 h, n = 93	P value
ERCP intervention type, n (%)
Complete stone removal	250 (98.4)	101 (99)	149 (98)	0.533	184 (98.9)	92 (98.9)	92 (98.9)	1
Biliary stent insertion	4 (1.6)	1 (1)	3 (2)	0.533	2 (1.1)	1 (1.1)	1 (1.1)	1
Technical success rate, n (%)	250 (98.4)	101(99)	149 (98)	0.533	183 (98.4)	92 (98.9)	91 (98)	0.561
ERCP failure, n (%)	4 (1.6)	1 (1)	3 (2)	0.533	3 (1.6)	1 (1.1)	2 (2.2)	1
Duration of antibiotic use (d)	7 (1-28)	6 (2-15)	8 (2-26)	< 0.001	7 (2-28)	6 (2-18)	9 (2-28)	< 0.001
In-hospital mortality, n (%)	3 (1.2)	0	3 (2)	0.153	2 (1.1)	0	2 (2.2)	0.155
30-d mortality, n (%)	7 (2.8)	2 (2)	5 (3.3)	0.526	5 (2.7)	2 (2.2)	3 (3.2)	0.65
Recurrent cholangitis, n (%)	7 (2.8)	3 (2.9)	4 (2.6)	0.883	6 (3.2)	3 (3.2)	3 (3.2)	1
LOHS, (d)	10 (3-71)	9 (3-39)	18 (5-71)	< 0.001	9 (3-71)	9 (3-39)	18.5 (7-71)	< 0.001
Required ICU stay, n (%)	61 (24)	33 (32.4)	28 (18.4)	0.011	52 (28)	32 (34.4)	20 (21.5)	0.05
ICU stay length, (d)	9 (1-71)	3 (1-15)	8 (1-71)	0.003	4.5 (1-71)	3 (1-15)	9 (1-71)	< 0.001
30 d readmission, n (%)	33 (13)	15 (14.7)	18 (11.8)	0.506	29 (15.6)	14 (15.1)	15 (16.1)	0.84
ERCP-related complications, n (%)	42 (16.5)	18 (17.7)	24 (15.8)	0.696	29 (15.6)	16 (17.2)	13 (14)	0.544
PEP	23 (9.1)	9 (8.8)	14 (9.2)	0.916	17 (9.1)	9 (9.7)	8 (8.6)	0.799
Cholangitis	9 (3.5)	6 (5.9)	3 (2)	0.099	7 (3.8)	5 (5.4)	2 (2.2)	0.248
Bleeding	6 (2.4)	4 (3.9)	2 (1.3)	0.18	4 (2.2)	3 (3.2)	1 (1.1)	0.312
Others	2 (0.8)	2 (2)	0	0.083	2 (1.1)	2 (2.2)	0	0.155

ERCP: Endoscopic retrograde cholangiopancreatography; LOHS: Length of hospital stay; PEP: Post-endoscopic retrograde cholangiopancreatography pancreatitis; ICU: Intensive care unit.